Lantheus Holdings, Inc. Long-Term Debt
Lantheus Holdings, Inc. (LNTH) had Long-Term Debt of $557.71 million as of 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2023-02-23
- 2022-12-31: Long-term Debt, Excluding Current Maturities $557.71M.
- 2021-12-31: Long-term Debt, Excluding Current Maturities $163.12M.
- 2021-03-31: Long-term Debt, Excluding Current Maturities $171.47M.
- 2020-12-31: Long-term Debt, Excluding Current Maturities $197.70M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2022-12-31 | $557.71M 10-K · filed 2023-02-23 |
| 2021-12-31 | $163.12M 10-K · filed 2023-02-23 |
| 2021-03-31 | $171.47M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $197.70M 10-K · filed 2022-02-24 |
| 2020-09-30 | $204.67M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $210.01M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $181.49M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $183.93M 10-K · filed 2021-02-25 |
| 2019-09-30 | $186.37M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $188.71M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $263.29M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $263.71M 10-K · filed 2020-02-25 |
| 2018-09-30 | $264.13M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $264.55M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $264.97M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $265.39M 10-K · filed 2019-02-20 |
| 2017-09-30 | $265.52M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $265.93M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $266.33M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $274.46M 10-K · filed 2018-02-26 |
| 2016-09-30 | $294.58M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $348.84M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $349.35M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $349.86M 10-K · filed 2017-02-23 |
| 2015-09-30 | $350.37M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $350.93M 10-Q · filed 2015-08-05 |
| 2014-12-31 | $392.86M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |